[Mifepristone and misoprostol in therapeutic abortions].
OBJECTIVE
To report our experience with the mifepristone and misoprostol combination in second and third trimester medically induced abortion.


METHODS
Prospective study without control group between January 1993 and december 1994.


METHODS
Saint-Antoine Hospital, Paris.


METHODS
Fifty-three patients admitted for a medically induced abortion.


RESULTS
Induction-to-abortion mean time was 12.9 +/- 7.5 hours (time distinctly decreased in fetal death: 8.3 +/- 4.4 hours).


CONCLUSIONS
The combination of misoprostol with mifepristone has equivalent with the other protocol used for therapeutic pregnancy termination, is less expensive (25 to 100 times) and finally is simple and non-invasive.
Jannet
D
D
Service de Gynécologie-Obstétrique, Hôpital Saint-Antoine, Paris.
Aflak
N
N
Chemla
J P
JP
Marpeau
L
L
Milliez
J
J
D000020:Abortifacient Agents, Nonsteroidal / Q000191:economics; D000021:Abortifacient Agents, Steroidal / Q000191:economics; D000032:Abortion, Therapeutic / Q000379:methods*; D000328:Adult; D016527:Drug Costs; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D015735:Mifepristone / Q000191:economics; D016595:Misoprostol / Q000191:economics; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D011263:Pregnancy Trimester, Third; D011446:Prospective Studies; D013997:Time Factors; D016896:Treatment Outcome
D000020:Abortifacient Agents, Nonsteroidal; D000021:Abortifacient Agents, Steroidal; D016595:Misoprostol; D015735:Mifepristone
Mifépristone et misoprostol dans les interruptions médicales de grossesses.